FDA Grants AP Status for MESNA ANDA203364 Submission by RISING
The FDA has granted an Abbreviated Approval (AP) status for the MESNA ANDA203364 submission from RISING.
Asset / Drug
Drug and asset intelligence for RISING with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.